Navigation Links
Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
Date:9/24/2008

BOSTON, Sept. 24 /PRNewswire-FirstCall/ -- Cancer treatment specialists reported yesterday how new technologies are enabling them to provide faster, more accurate cancer treatments than was possible with earlier generations of radiotherapy technology. In presentations given at an "Emerging Technologies" Symposium sponsored by Varian Medical Systems (NYSE: VAR) in connection with the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), doctors detailed how they are using RapidArc(TM) radiotherapy technology, as well as cone-beam CT (3-D) imaging to offer their patients highly-accurate and more comfortable cancer treatments.

The symposium presentations began with Clif Ling, PhD, a renowned expert in the fields of medical physics and radiation oncology. In his talk entitled "Affirming the past -- anticipating the future -- comments during the 50th Anniversary of ASTRO" he provided a history of the technological advances, many of which were provided by Varian, that have led to improved clinical outcomes and increased survival among cancer patients treated with radiotherapy. According to Ling, the technical advances in radiation oncology can be summarized in four categories:

1) Improvements in imaging, which made it possible to see a tumor and its

surrounding normal tissues, and to create treatment plans based on a

patient's unique anatomy.

2) Advances in the design and optimization of treatment plans, thanks to

computer algorithms that work with volumetric (3-D) CT image data to

calculate an optimal way of delivering the desired radiation dose in

three dimensions.

3) Improvements to treatment delivery systems, including sophisticated
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
2. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
3. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
4. Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children
5. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
6. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
7. Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
8. Promise of Vicals CMV Vaccine Noted by Independent Experts
9. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
10. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
11. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , PISCATAWAY, N.J., Dec. 3 /PRNewswire-F...in Board: MLSS), the recognized leader in advanced...ad entered into a joint venture with China Nationa...nd Yichang Humanwell Pharmaceutical Co. Ltd., both...he "PRC"), to develop orthopedic and epidural drug...
(Date:12/3/2009)... , MAPLE GROVE, Minn., Dec. 3 /PRNewswire/...d the next phase of its strategic plan for central...ed release topiramate), an internally developed pr...ing developed with Upsher-Smith,s proprietary form...ical trial in early 2010 for the adjunctive treatm...
(Date:12/3/2009)... , ROCHESTER, N.Y., Dec. 3 /PRNewswire-FirstCal...ading provider of quantitative imaging for clinica...System and Method for 4D Reconstruction and Visual..., VirtualScopics, Vice President of Technology and...We are pleased that Japan has recognized the uniqu...
Breaking Medicine Technology:Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Upsher-Smith Announces Milestone in Development of CNS Strategy 2VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3A study to prevent sudden death in sports by means of genetic testing 59151 1A study to prevent sudden death in sports by means of genetic testing 59151 2EPA awards competitive grants for students to design sustainable technologies that help environment and economy 10301 1Buffalo Bills Quarterback Trent Edwards Rallies Around The ALS Association 59149 1Buffalo Bills Quarterback Trent Edwards Rallies Around The ALS Association 59149 2Buffalo Bills Quarterback Trent Edwards Rallies Around The ALS Association 59149 3Buffalo Bills Quarterback Trent Edwards Rallies Around The ALS Association 59149 4
..., Dec. 1 S*BIO Pte Ltd today announced the initia...tent and orally-active JAK2 inhibitor, in leading ...onic idiopathic myelofibrosis (CIMF). , , Th...erability of SB1518 in patients with CIMF and is e...art of the study will assess the safety profile an...
...MEETING, Pa., Dec. 1 Genaera Corporation (Nasdaq... has begun in study MSI-1436C-102 (Study 102), the...uemine (MSI-1436) in overweight and obese type 2 d...treatment of type 2 diabetes and obesity which wor...and leptin pathways through the highly selective i...
Other Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3
(Date:12/3/2009)...io Badescu Skin Care,s cult favorite Drying Lotion...receiving a 2009 ELLE Beauty Award , ...scu Skin Care,s Drying Lotion has long been a cult...ers, and skin care divas, but its selection by ELL...siderable leap into the mainstream limelight., , ,...
(Date:12/3/2009)...nomic downturn causes demand for affordable drug a...icut cites a sharp increase in demand for its serv...is which has led to an increase in alcoholic binge... (PRWEB) December 3, 2009 -- M...sees a huge spike in demand for its services due t...
(Date:12/3/2009)...linger about whether they cause brain cancer, , ...ether cell phones cause brain cancer has been a su...previous evidence suggesting that they don,t. ,...umors in Scandinavia found no substantial change i...spread, according to the report in the Dec. 3 onli...
(Date:12/3/2009)...f., Dec. 3 The Board of...udies unanimously voted to elect three new member...red Dotzler is co-founder and Managing Director o... investing $650 million from three funds in early ...Dotzler founded Medicus Venture Partners in 1989. ...
(Date:12/3/2009)...nalysis understates key factors contributing to in...wswire/ -- A new actuarial analysis by Oliver Wyma...n the new individual market will be 54 percent hig...ation of healthcare reform under the Patient Prote...he impact of medical inflation. This would transl...
Breaking Medicine News(10 mins):Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4
... high levels of D-dimer face greatest chance of tr...s) -- Levels of certain blood markers may increase...acement therapy to relieve symptoms of menopause, ...presented Saturday at the American Society of Hema...
...er 8, 2007 There is a clear link between GABA a c...at inhibits neurons in the brain and nicotine de...the American College of Neuropsychopharmacology (A...urable effects of nicotine and help people break t...
... proteins could determine if more invasive treatme...Y, Dec. 7 (HealthDay News) -- It may be possible t...g to a Duke University Medical Center-led study. ... -- may provide a simple follow-up for patients wh...
.... 7 Universal Health,Services, Inc. (NYSE: UHS )...rized an additional 5 million share repurchase pro...under previously announced authorizations.,Pursuan... transactions., Universal Health Services, Inc. i...
... held Wednesday, December 12 at Facility, PLANO, ...ealth and Rehab Center in Dallas will have a safer...ogram that ViewPoint Bank is,sponsoring at the fac...in the nation,s senior housing facilities., "Crim...
... A recent study by Best,Practices, LLC found that...roduct Introduction team was one of the most impor...Ensuring a Successful New Product Launch,Through E...e success of product launches., You can download ...
Other Medicine News:Health News:Blood Markers Might Predict Clotting Risk With HRT 2Health News:Blood Markers Might Predict Clotting Risk With HRT 3Health News:Study suggests nicotine addiction might be controlled by influencing brain mechanisms 2Health News:Blood Test to Detect Lung Cancer Being Eyed 2Health News:ViewPoint Bank Funds Senior Crimestoppers Program at Meadows Health and Rehab Center in Dallas 2Health News:Best Practice Database: Complimentary Excerpt of 'Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles' 2
Josephine Vest V-65
Female Bra Vest
Scrotum Support
Support Brief
Medicine Products: